๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells

โœ Scribed by Guan-Nan Zhang; Yi Liang; Ling-Jun Zhou; Shu-Peng Chen; Ge Chen; Tai-Ping Zhang; Tiebang Kang; Yu-Pei Zhao

Book ID
116335684
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
930 KB
Volume
313
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Gemcitabine and platinum combinations in
Gemcitabine and platinum combinations in pancreatic cancer
โœ Philip Agop Philip ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 62 KB

Progress in the treatment of pancreatic cancer in the past several decades has been very modest. Several new agents with activity against this disease have been identified. Of these, gemcitabine appears to be the most promising when used in combination with other drugs. Gemcitabine and cisplatin com

The pemetrexed/gemcitabine combination i
The pemetrexed/gemcitabine combination in pancreatic cancer
โœ Hedy Lee Kindler ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 89 KB

Gemcitabine has modest antitumor activity in advanced pancreatic cancer. New agents are clearly needed. Pemetrexed (ALIMTA) is a novel antifolate that inhibits thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase. Pemetrexed has shown in vitro activity agai